Cancer treatment
Anixa Biosciences has announced that the Chinese National Intellectual Property Administration (CNIPA) has issued a patent for its breast cancer vaccine technology, providing IP protection in China until 2040. This expandable patent estate will allow Anixa to pursue strategic global opportunities in regions with high breast cancer incidence. The breast
Cancer research
According to a recent study published in Frontiers in Oncology, researchers from the Affiliated Tumor Hospital of Xinjiang Medical University have investigated the clinical characteristics, overall survival, and prognostic factors associated with breast cancer patients who have ovarian metastasis. The study analyzed 41 breast cancer patients with pathologically confirmed ovarian
Cancer research
A new study conducted by researchers at the University of Naples Federico II has evaluated the efficacy and safety of a polynucleotide-based vaginal cream for treating genitourinary syndrome of menopause (GSM) in breast cancer patients receiving adjuvant therapy. The study found that the cream effectively managed GSM symptoms and was
Cancer research
Research conducted at the Breast Center of the Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, People's Republic of China, has revealed a potential link between platelet indices and an increased risk of breast cancer, specifically in estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) subtypes. The study,
Cancer research
Premenopausal patients with estrogen receptor-positive breast cancer are at risk of experiencing bone mineral density loss due to ovarian function suppression (OFS), while tamoxifen-only treatment shows minimal impact on bone health. According to a recent study published in Frontiers in Oncology, the addition of OFS to tamoxifen-only treatment led to
Cancer research
A groundbreaking study published in the Journal of Clinical Oncology has shown that denosumab therapy can effectively preserve bone density and strength in premenopausal women with early-stage breast cancer who are undergoing estradiol suppression therapy. The research, conducted by a team of scientists at the University of Melbourne, aimed to
B cells
Data from a prospective observational study conducted at the Arnau de Vilanova Hospital in Valencia, Spain, has revealed significant insights into the immune response of breast cancer patients undergoing active treatment. The research, focusing on the immunogenicity of SARS-CoV-2 mRNA vaccine in this population, demonstrated a strong humoral response with
Cancer research
Contrast-enhanced mammography (CEM) has emerged as a valuable tool in breast cancer screening, offering enhanced diagnostic accuracy compared to standard mammography. Researchers from Ohio State University Wexner Medical Center have published a study in RadioGraphics, highlighting the benefits and limitations of CEM in clinical practice. The study emphasizes the importance
Charities
A new partnership between InformedDNA and the Know Your Lemons Foundation aims to provide personalized screening recommendations and genetic counseling services to individuals at various risk levels for breast cancer. The collaboration extends the mission of Know Your Lemons to provide breast cancer education and guidance, leveraging InformedDNA's
Charities
To coincide with Breast Cancer Awareness Month, SuperValu and Centra have launched a campaign to raise funds for Action Cancer, aiming to collect a minimum of £120 per store, the cost of a free mammogram for women outside the NHS screening age range. This year, Action Cancer's mobile
Cancer research
La-Urshalar Brock, an Emory University nursing PhD student, has been awarded the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship from the National Institutes of Health (NIH). This highly competitive award supports promising predoctoral students conducting mentored research that contributes to the nation's health-related research
Cancer research
Advanced prostate cancer patients who are resistant to hormone therapy may find new hope in existing drugs designed for other cancers. According to a recent study by the Institute of Cancer Research in London, combining breast and blood cancer drugs could halt the growth of tumours in the prostate. This
